Universitätsklinikum Hamburg-Eppendorf - University Medical Center Hamburg-Eppendorf

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack	Acute Myocardial Infarction (AMI); Cardiovascular Risk	Active, not recruiting	Phase 3	2026-09-09		NCT06118281
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemolysis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sickle Cell Trait, Vaso-Occlusive Crises, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease	Active, not recruiting	Phase 3	2026-04-06		NCT04624659

Clinical trials